Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Dyslipidemia

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 139 articles: HTML format

Single Articles

June 2008
1. NAGASAKA H , Miida T, Hirano K, Ota A, et al
   Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome.
   Atherosclerosis. 2008;198:434-40.
   PubMed     Related articles    Abstract available
   
   
   
2. THOMPSON GR
   Recommendations for the use of LDL apheresis.
   Atherosclerosis. 2008;198:247-55.
   PubMed     Related articles    Abstract available
   
   
   
3. ARAMAKI Y , Mitsuoka H, Toyohara M, Jinnai T, et al
   Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells.
   Atherosclerosis. 2008;198:272-9.
   PubMed     Related articles    Abstract available
   
   
   May 2008
4. ANUURAD E , Thomas-Geevarghese A, Devaraj S, Albu J, et al
   Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy.
   Atherosclerosis. 2008;198:192-7.
   PubMed     Related articles    Abstract available
   
   
   
5. GOUNI-BERTHOLD I , Berthold HK, Gylling H, Hallikainen M, et al
   Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
   Atherosclerosis. 2008;198:198-207.
   PubMed     Related articles    Abstract available
   
   
   
6. NAKAJIMA K , Nakajima Y, Takeichi S, Fujita MQ, et al
   Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
   Atherosclerosis. 2008;198:237-46.
   PubMed     Related articles    Abstract available
   
   
   April 2008
7. REIMANN M , Schutte AE, Malan L, Huisman HW, et al
   Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis.
   Atherosclerosis. 2008;197:638-45.
   PubMed     Related articles    Abstract available
   
   
   
8. BO M , Comba M, Canade' A, Brescianini A, et al
   Clinical implications of white-coat effect among patients attending at a lipid clinic.
   Atherosclerosis. 2008;197:904-9.
   PubMed     Related articles    Abstract available
   
   
   
9. STIRNADEL H , Lin X, Ling H, Song K, et al
   Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
   Atherosclerosis. 2008;197:868-76.
   PubMed     Related articles    Abstract available
   
   
   
10. MAUSNER-FAINBERG K , Luboshits G, Mor A, Maysel-Auslender S, et al
    The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Atherosclerosis. 2008;197:829-39.
    PubMed     Related articles    Abstract available
    
    
    
11. KOTSEVA K , Stagmo M, De Bacquer D, De Backer G, et al
    Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey.
    Atherosclerosis. 2008;197:710-7.
    PubMed     Related articles    Abstract available
    
    
    
12. PIRRO M , Schillaci G, Bagaglia F, Menecali C, et al
    Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.
    Atherosclerosis. 2008;197:757-67.
    PubMed     Related articles    Abstract available
    
    
    
13. VAVERKOVA H , Karasek D, Novotny D, Jackuliakova D, et al
    Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia.
    Atherosclerosis. 2008;197:725-31.
    PubMed     Related articles    Abstract available
    
    
    
14. SVIRIDOV D , Hoang A, Ooi E, Watts G, et al
    Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.
    Atherosclerosis. 2008;197:732-9.
    PubMed     Related articles    Abstract available
    
    
    
15. MAKINEN JI , Perheentupa A, Irjala K, Pollanen P, et al
    Endogenous testosterone and serum lipids in middle-aged men.
    Atherosclerosis. 2008;197:688-93.
    PubMed     Related articles    Abstract available
    
    
    March 2008
16. DE SOUZA JA , Vindis C, Hansel B, Negre-Salvayre A, et al
    Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
    Atherosclerosis. 2008;197:84-94.
    PubMed     Related articles    Abstract available
    
    
    
17. DE HAAN W , van der Hoogt CC, Westerterp M, Hoekstra M, et al
    Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    Atherosclerosis. 2008;197:57-63.
    PubMed     Related articles    Abstract available
    
    
    
18. LEINO-ARJAS P , Kauppila L, Kaila-Kangas L, Shiri R, et al
    Serum lipids in relation to sciatica among Finns.
    Atherosclerosis. 2008;197:43-9.
    PubMed     Related articles    Abstract available
    
    
    
19. BELLASI A , Veledar E, Ferramosca E, Ratti C, et al
    Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile.
    Atherosclerosis. 2008;197:242-9.
    PubMed     Related articles    Abstract available
    
    
    
20. RIZZO M , Pernice V, Frasheri A, Berneis K, et al
    Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.
    Atherosclerosis. 2008;197:237-41.
    PubMed     Related articles    Abstract available
    
    
    
21. HAYASHI T , Hirano T, Taira T, Tokuno A, et al
    Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease.
    Atherosclerosis. 2008;197:154-8.
    PubMed     Related articles    Abstract available
    
    
    February 2008
22. IWASE M , Sonoki K, Sasaki N, Ohdo S, et al
    Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
    Atherosclerosis. 2008;196:931-6.
    PubMed     Related articles    Abstract available
    
    
    
23. JORGENSEN ME , Bjerregaard P, Kjaergaard JJ, Borch-Johnsen K, et al
    High prevalence of markers of coronary heart disease among Greenland Inuit.
    Atherosclerosis. 2008;196:772-8.
    PubMed     Related articles    Abstract available
    
    
    
24. SUMNER AE , Cowie CC
    Ethnic differences in the ability of triglyceride levels to identify insulin resistance.
    Atherosclerosis. 2008;196:696-703.
    PubMed     Related articles    Abstract available
    
    
    January 2008
25. ROSENSON RS , Huskin AL, Wolff DA, Helenowski IB, et al
    Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. KOH KK , Quon MJ, Waclawiw MA
    Are statins effective for simultaneously treating dyslipidemias and hypertension?
    Atherosclerosis. 2008;196:1-8.
    PubMed     Related articles    Abstract available
    
    
    
27. PHUNTUWATE W , Suthisisang C, Koanantakul B, Chaloeiphap P, et al
    Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels.
    Atherosclerosis. 2008;196:122-8.
    PubMed     Related articles    Abstract available
    
    
    
28. JADDOE VW , de Ridder MA, van den Elzen AP, Hofman A, et al
    Maternal smoking in pregnancy is associated with cholesterol development in the offspring: A 27-years follow-up study.
    Atherosclerosis. 2008;196:42-8.
    PubMed     Related articles    Abstract available
    
    
    
29. MIYAKE Y , Kimura R, Kokubo Y, Okayama A, et al
    Genetic variants in PCSK9 in the Japanese population: rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population.
    Atherosclerosis. 2008;196:29-36.
    PubMed     Related articles    Abstract available
    
    
    December 2007
30. ZAWADZKI C , Susen S, Richard F, Haulon S, et al
    Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
    Atherosclerosis. 2007;195:e117-25.
    PubMed     Related articles    Abstract available
    
    
    November 2007
31. BOURBON M , Sun XM, Soutar AK
    A rare polymorphism in the low density lipoprotein (LDL) gene that affects mRNA splicing.
    Atherosclerosis. 2007;195:e17-20.
    PubMed     Related articles    Abstract available
    
    
    
32. ATTIA N , Ramaharo A, Paul JL, Cambillau M, et al
    Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
33. PISCIOTTA L , Fasano T, Calabresi L, Bellocchio A, et al
    A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. TALMUD PJ
    Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
    Atherosclerosis. 2007;194:287-92.
    PubMed     Related articles    Abstract available
    
    
    
35. GASPAROVIC J , Basistova Z, Fabryova L, Wsolova L, et al
    Familial defective apolipoprotein B-100 in Slovakia: are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity?
    Atherosclerosis. 2007;194:e95-107.
    PubMed     Related articles    Abstract available
    
    
    
36. PISCIOTTA L , Fasano T, Bellocchio A, Bocchi L, et al
    Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.
    Atherosclerosis. 2007;194:e116-22.
    PubMed     Related articles    Abstract available
    
    
    
37. CUI R , Iso H, Toyoshima H, Date C, et al
    Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study.
    Atherosclerosis. 2007;194:415-20.
    PubMed     Related articles    Abstract available
    
    
    September 2007
38. MASCITELLI L , Pezzetta F
    Does hypercholesterolemia impair left ventricular function?
    Atherosclerosis. 2007;.
    PubMed     Related articles   
    
    
    
39. SANTOS RD , Miname MH, Martinez LR, Rochitte CE, et al
    Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. MEUWESE MC , Trip MD, van Wissen S, van Miert JN, et al
    Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. MAZOR R , Shurtz-Swirski R, Farah R, Kristal B, et al
    Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. HOLVOET P , Jenny NS, Schreiner PJ, Tracy RP, et al
    The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2007;194:245-52.
    PubMed     Related articles    Abstract available
    
    
    
43. KOH KK , Quon MJ, Han SH, Ahn JY, et al
    Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.
    Atherosclerosis. 2007;194:230-7.
    PubMed     Related articles    Abstract available
    
    
    
44. HURRELL C , Wietlisbach V, Jotterand V, Volet M, et al
    High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease--the GENECARD project.
    Atherosclerosis. 2007;194:253-64.
    PubMed     Related articles    Abstract available
    
    
    
45. SAITO I , Sato S, Nakamura M, Kokubo Y, et al
    A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study.
    Atherosclerosis. 2007;194:238-44.
    PubMed     Related articles    Abstract available
    
    
    
46. GEORGOPOULOS A , Bloomfield H, Collins D, Brousseau ME, et al
    Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).
    Atherosclerosis. 2007;194:169-74.
    PubMed     Related articles    Abstract available
    
    
    August 2007
47. BOURBON M , Alves AC, Medeiros AM, Silva S, et al
    Familial hypercholesterolaemia in Portugal.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. HOMER VM , Marais AD, Charlton F, Laurie AD, et al
    Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. MARAIS AD , Raal FJ, Stein EA, Rader DJ, et al
    A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. JUNYENT M , Zambon D, Gilabert R, Cofan M, et al
    Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. MABUCHI H , Nohara A, Kobayashi J, Kawashiri MA, et al
    Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. HOOPER AJ , Marais AD, Tanyanyiwa DM, Burnett JR, et al
    The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population.
    Atherosclerosis. 2007;193:445-8.
    PubMed     Related articles    Abstract available
    
    
    July 2007
53. TALINI E , Di Bello V, Bianchi C, Palagi C, et al
    Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. FUJII A , Allen TJ, Nestel PJ
    A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
    Atherosclerosis. 2007;193:55-61.
    PubMed     Related articles    Abstract available
    
    
    
55. CHERFAN P , Tompa A, Wikby A, Lofgren S, et al
    Effects of simvastatin on human T cells in vivo.
    Atherosclerosis. 2007;193:186-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
56. BLAHA M , Cermanova M, Blaha V, Jarolim P, et al
    Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. BENITEZ MB , Cuniberti L, Fornari MC, Rosso LG, et al
    Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. THOMAS EL , Potter E, Tosi I, Fitzpatrick J, et al
    Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. SCHLAICH MP , Oehmer S, Schneider MP, Delles C, et al
    Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Atherosclerosis. 2007;192:155-60.
    PubMed     Related articles    Abstract available
    
    
    
60. PRESTON RA , Coffey JO, Materson BJ, Ledford M, et al
    Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension.
    Atherosclerosis. 2007;192:148-54.
    PubMed     Related articles    Abstract available
    
    
    
61. MURDOCH SJ , Boright AP, Paterson AD, Zinman B, et al
    LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
    Atherosclerosis. 2007;192:138-47.
    PubMed     Related articles    Abstract available
    
    
    April 2007
62. EVANS K , Burdge GC, Wootton SA, Collins JM, et al
    Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. AESSOPOS A , Farmakis D, Tsironi M, Diamanti-Kandarakis E, et al
    Endothelial function and arterial stiffness in sickle-thalassemia patients.
    Atherosclerosis. 2007;191:427-32.
    PubMed     Related articles    Abstract available
    
    
    
64. MARTINELLI N , Trabetti E, Bassi A, Girelli D, et al
    The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Atherosclerosis. 2007;191:409-17.
    PubMed     Related articles    Abstract available
    
    
    March 2007
65. BERNIER L , Boulet L, Roy M, Dufour R, et al
    Two new large deletions in the low density lipoprotein receptor (LDLR) gene not revealed by PCR-based molecular diagnosis of familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. ALCALA A , Jansen S, Farkouh ME, Morell M, et al
    Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. ONAT A , Uyarel H, Hergenc G, Karabulut A, et al
    Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
    Atherosclerosis. 2007;191:182-90.
    PubMed     Related articles    Abstract available
    
    
    
68. MARTINEAU P , Gaw A, de Teresa E, Farsang C, et al
    Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
    Atherosclerosis. 2007;191:135-46.
    PubMed     Related articles    Abstract available
    
    
    
69. ZHANG B , Bottcher A, Imaizumi S, Noda K, et al
    Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels.
    Atherosclerosis. 2007;191:153-61.
    PubMed     Related articles    Abstract available
    
    
    February 2007
70. OTT C , Schlaich MP, Schmidt BM, Titze SI, et al
    Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. YOUNG RS , Naseem KM, Pasupathy S, Ahilathirunayagam S, et al
    Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
    Atherosclerosis. 2007;190:452-8.
    PubMed     Related articles    Abstract available
    
    
    
72. CHEN W , Li S, Srinivasan SR, Boerwinkle E, et al
    A genome scan for loci influencing levels and trends of lipoprotein lipid-related traits since childhood: The Bogalusa Heart Study.
    Atherosclerosis. 2007;190:248-55.
    PubMed     Related articles    Abstract available
    
    
    
73. BOHLER S , Scharnagl H, Freisinger F, Stojakovic T, et al
    Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany.
    Atherosclerosis. 2007;190:397-407.
    PubMed     Related articles    Abstract available
    
    
    January 2007
74. DE VRIES R , Groen AK, Perton FG, Dallinga-Thie GM, et al
    Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. SOROKIN A , Brown JL, Thompson PD
    Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. LEITER LA , Rosenson RS, Stein E, Reckless JP, et al
    Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. SAITO Y , Yamada N, Shirai K, Sasaki J, et al
    Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. WAKKEE M , Thio HB, Prens EP, Sijbrands EJ, et al
    Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
    Atherosclerosis. 2007;190:1-9.
    PubMed     Related articles    Abstract available
    
    
    
79. CHURCH TS , Levine BD, McGuire DK, Lamonte MJ, et al
    Coronary artery calcium score, risk factors, and incident coronary heart disease events.
    Atherosclerosis. 2007;190:224-31.
    PubMed     Related articles    Abstract available
    
    
    
80. OKAMURA T , Tanaka H, Miyamatsu N, Hayakawa T, et al
    The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.
    Atherosclerosis. 2007;190:216-23.
    PubMed     Related articles    Abstract available
    
    
    
81. VAN OOSTROM AJ , Alipour A, Plokker TW, Sniderman AD, et al
    The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers.
    Atherosclerosis. 2007;190:167-73.
    PubMed     Related articles    Abstract available
    
    
    
82. BOGANI P , Galli C, Villa M, Visioli F, et al
    Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil.
    Atherosclerosis. 2007;190:181-6.
    PubMed     Related articles    Abstract available
    
    
    December 2006
83. AYAORI M , Momiyama Y, Fayad ZA, Yonemura A, et al
    Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
84. CAMPAGNA F , Martino F, Bifolco M, Montali A, et al
    Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
85. PETTERSSON K , Kjerrulf M, Jungersten L, Johansson K, et al
    The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
86. AI M , Tanaka A, Shoji K, Ogita K, et al
    Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
87. BOUHALI T , Brisson D, St-Pierre J, Tremblay G, et al
    Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
88. ARAMBEPOLA C , Farmer AJ, Perera R, Neil HA, et al
    Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
89. TOSI I , Toledo-Leiva P, Neuwirth C, Naoumova RP, et al
    Genetic defects causing familial hypercholesterolaemia: Identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
90. NORATA GD , Grigore L, Raselli S, Redaelli L, et al
    Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
91. BASISTOVA Z , Gasparovic J, Sivakova D, Raslova K, et al
    H3543Y mutation of apoB-100 in patients with phenotype of familial hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   
    
    
    
92. SOLFRIZZI V , Capurso C, Colacicco AM, D'Introno A, et al
    Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2006;188:455-61.
    PubMed     Related articles    Abstract available
    
    
    
93. BANEGAS JR , Vegazo O, Serrano P, Luengo E, et al
    The gap between dyslipidemia control perceived by physicians and objective control patterns in Spain.
    Atherosclerosis. 2006;188:420-4.
    PubMed     Related articles    Abstract available
    
    
    September 2006
94. NAKAMURA T , Kodama Y, Takano H, Umetani K, et al
    Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   
    
    
    
95. PUCCI A , Sheiban I, Formato L, Celeste A, et al
    In vivo coronary plaque histology in patients with stable and acute coronary syndromes Relationships with hyperlipidemic status and statin treatment.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
96. SEIP RL , Otvos J, Bilbie C, Tsongalis GJ, et al
    The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise.
    Atherosclerosis. 2006;188:126-33.
    PubMed     Related articles    Abstract available
    
    
    
97. FLOREZ H , Mendez A, Casanova-Romero P, Larreal-Urdaneta C, et al
    Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.
    Atherosclerosis. 2006;188:134-41.
    PubMed     Related articles    Abstract available
    
    
    August 2006
98. BUDOFF MJ , Nasir K, Mao S, Tseng PH, et al
    Ethnic differences of the presence and severity of coronary atherosclerosis.
    Atherosclerosis. 2006;187:343-50.
    PubMed     Related articles    Abstract available
    
    
    July 2006
99. LOBODA A , Jazwa A, Jozkowicz A, Dorosz J, et al
    Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.
    Atherosclerosis. 2006;187:26-30.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
100. ROSENBLAT M , Karry R, Aviram M
     Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
     Atherosclerosis. 2006;187:74-81.
     PubMed     Related articles    Abstract available
     
     
     June 2006
101. HENNEMAN P , Schaap FG, Havekes LM, Rensen PC, et al
     Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
102. OIKAWA S , Kita T, Mabuchi H, Matsuzaki M, et al
     Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: Implication from Japan Lipid Intervention Trial (J-LIT).
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     May 2006
103. GRAHAM CA , Wright WT, McIlhatton BP, Young IS, et al
     The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
     Atherosclerosis. 2006;.
     PubMed     Related articles   
     
     
     
104. OLIVA CP , Pisciotta L, Guardamagna O, Bellocchio A, et al
     A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia.
     Atherosclerosis. 2006;.
     PubMed     Related articles   
     
     
     
105. TER AVEST E , Holewijn S, Bredie SJ, Stalenhoef AF, et al
     Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH).
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     April 2006
106. SKILTON MR , Moulin P, Serusclat A, Nony P, et al
     A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
107. NAISSIDES M , Mamo JC, James AP, Pal S, et al
     The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women.
     Atherosclerosis. 2006;185:438-45.
     PubMed     Related articles    Abstract available
     
     
     March 2006
108. HOGUE JC , Lamarche B, Gaudet D, Tremblay AJ, et al
     Association of heterozygous familial hypercholesterolemia with smaller HDL particle size.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
109. ERHARDT LR , Gotto A Jr
     The evolution of European guidelines: changing the management of cholesterol levels.
     Atherosclerosis. 2006;185:12-20.
     PubMed     Related articles    Abstract available
     
     
     
110. FISHER SD , Miller TL, Lipshultz SE
     Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis.
     Atherosclerosis. 2006;185:1-11.
     PubMed     Related articles    Abstract available
     
     
     
111. LAAKSONEN R , Thelen KM, Paiva H, Matinheikki J, et al
     Genetic variant of the SREBF-1 gene is significantly related to cholesterol synthesis in man.
     Atherosclerosis. 2006;185:206-9.
     PubMed     Related articles    Abstract available
     
     
     
112. KIORTSIS DN , Argyropoulou MI, Tsouli SG, Xydis V, et al
     Correlation of Achilles tendon thickness evaluated by ultrasonography with carotid intima-media thickness in patients with familial hypercholesterolemia.
     Atherosclerosis. 2006;.
     PubMed     Related articles   
     
     
     February 2006
113. GIRAL P , Kahn JF, Andre JM, Carreau V, et al
     Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patients.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
114. HAN SH , Koh KK, Quon MJ, Lee Y, et al
     The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
115. DURST R , Jansen A, Erez G, Bravdo R, et al
     The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
116. AMUNDSEN AL , Khoury J, Iversen PO, Bergei C, et al
     Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia.
     Atherosclerosis. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
117. HOENIG MR , Rolfe BE, Campbell JH
     Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy.
     Atherosclerosis. 2006;184:247-54.
     PubMed     Related articles    Abstract available
     
     
     
118. KOSUGE K , Miida T, Takahashi A, Obayashi K, et al
     Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations.
     Atherosclerosis. 2006;184:413-9.
     PubMed     Related articles    Abstract available
     
     
     
119. TAN KC , Chow WS, Lam JC, Lam B, et al
     HDL dysfunction in obstructive sleep apnea.
     Atherosclerosis. 2006;184:377-82.
     PubMed     Related articles    Abstract available
     
     
     January 2006
120. BOUDIK F , Reissigova J, Hrach K, Tomeckova M, et al
     Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results.
     Atherosclerosis. 2006;184:86-93.
     PubMed     Related articles    Abstract available
     
     
     
121. LI ZY , Xu GB, Xia TA
     Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing.
     Atherosclerosis. 2006;184:188-92.
     PubMed     Related articles    Abstract available
     
     
     
122. PEREIRA AC , Sposito AC, Mota GF, Cunha RS, et al
     Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure.
     Atherosclerosis. 2006;184:193-200.
     PubMed     Related articles    Abstract available
     
     
     
123. COFAN F , Vela E, Cleries M
     Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia.
     Atherosclerosis. 2006;184:94-102.
     PubMed     Related articles    Abstract available
     
     
     December 2005
124. HALLIKAINEN M , Lyyra-Laitinen T, Laitinen T, Agren JJ, et al
     Endothelial function in hypercholesterolemic subjects: Effects of plant stanol and sterol esters.
     Atherosclerosis. 2005;.
     PubMed     Related articles    Abstract available
     
     
     
125. PISCIOTTA L , Oliva CP, Pes GM, Di Scala L, et al
     Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
126. TREMBLAY AJ , Lamarche B, Ruel IL, Hogue JC, et al
     Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     October 2005
127. CORSETTI JP , Zareba W, Moss AJ, Rainwater DL, et al
     Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     September 2005
128. TAI MH , Kuo SM, Liang HT, Chiou KR, et al
     Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
129. PISCIOTTA L , Oliva CP, Cefalu AB, Noto D, et al
     Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
130. ANTONOPOULOS S , Mikros S, Mylonopoulou M, Kokkoris S, et al
     Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.
     Atherosclerosis 2005;.
     PubMed     Related articles   
     
     
     August 2005
131. WRIGHT WT , Young IS, Nicholls DP, Patterson C, et al
     SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
132. HOCKERSTEDT A , Jauhiainen M, Tikkanen MJ
     Estradiol fatty acid esterification is increased in high density lipoprotein subclass 3 isolated from hypertriglyceridemic subjects.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
133. VAN OOSTROM AJ , Plokker HW, van Asbeck BS, Rabelink TJ, et al
     Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     July 2005
134. YAMAMOTO A , Harada-Shiba M, Endo M, Kusakabe N, et al
     The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
135. ROSENSON RS
     Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
136. VAN TITS LJ , van Himbergen TM, Lemmers HL, de Graaf J, et al
     Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
137. BERCOVICH D , Friedlander Y, Korem S, Houminer A, et al
     The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     May 2005
138. HOGUE JC , Lamarche B, Gaudet D, Tremblay AJ, et al
     Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     
     
139. BARROS MR , Bertolami MC, Abdalla DS, Ferreira WP, et al
     Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings.
     Atherosclerosis 2005;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: